Dr. Gai is the founding partner of Global Assets Investment, LLC. Previously she was a Vice President of the Direct Investment Group of Merrill Lynch in New York where she was a founding team member of the companys China direct investment initiative. She also worked at Tiger Management where she specialized in equity research in biotech and pharmaceutical industries, and private equity investment in US biotechnology companies.

Dr. Gai has over 20 years of experience in cross-cultural technological and business collaborations between China and other countries. Her experience in the field of venture capital and connections in investment and industrial circles in the US and China have made her successful in investing in life science companies and in advising corporate clients to identify cross-border technological and/or manufacturing partners.

Dr. Lipson is a partner in Global Assets Investment LLC, where he reviews and authorizes investment decisions and provides scientific expertise to the company and its clients. He has provided consulting services to two biotechnology companies working in the area of therapeutic antibody discovery, and a venture capital company focused on investments in China.

Dr. Lipson has more than 15 years of experience in biotechnology and multinational pharmaceutical companies, including 3M Pharmaceuticals, Pharmacia, SUGEN and CIBA-Geigy (now Novartis), He has served in a variety of scientific and business leadership positions, and worked in multiple therapeutic areas, including oncology, cardiovascular, inflammation, metabolic and infectious diseases, which are all represented in his more than 75 publications in peer-reviewed journals, patent applications, review articles and book chapters.

Prior to his industrial experience, Dr. Lipson served on the faculty of the department of Pathology at Temple University Medical School. Dr. Lipson earned two simultaneous BS degrees in Biology and Chemistry from the University of Toledo, and a Ph.D. in Chemistry from Case Western Reserve University. His postdoctoral studies at Sloan-Kettering Institute and Temple University Medical School provided additional training in biochemistry, pharmacology, cell biology and molecular biology.

Donald Gao is Principal of Global Assets LLC. His expertise is in investment valuation, deal structuring, M&A, portfolio company management, which includes performance measurement, strategic planning, turnaround, capital budgeting and enterprise risk management. His industry investment experiences range from healthcare management, biochemistry, alternative energy, agriculture & food to E-business and TMT. He is also responsible for business development and investor relations.

Mr. Gao held a position in Citigroup's fixed income division where he was involved in leveraged and high yield bond origination. Before that he held diplomatic positions as an Economic and Commercial Vice Consul to the US and as a Commercial Attache in India where he was responsible for China's overseas investment strategies and execution as well as building high level business community networks.

Donald Gao has earned a MBA from Harvard Business School. He is a Certified Management Accountant (USA), Charter Alternative Investment Analyst holder (CAIA) and FRM charter holder. He is also an American Mensa member.